Robin T. Varughese
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Robin T. Varughese has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
Sanjeev Kothare
Northwell, New Hyde Park, New York; Cohen Children's Medical Center, Pediatric Neurology, New Hyde Park, New York
3 shared publications- Christian Suri Baez
Cohen Children's Medical Center, Division of Pediatric Neurology, Northwell, New Hyde Park, New York
2 shared publications Christine Palladino
Northwell, New Hyde Park, New York; Division of Pediatric Neurology, Cohen Children's Medical Center, New Hyde Park, New York
2 shared publicationsIvan Pavkovic
Northwell, New Hyde Park, New York; Division of Pediatric Neurology, Cohen Children's Medical Center, New Hyde Park, New York
2 shared publicationsSanjeev V. Kothare
Northwell, New Hyde Park, New York; Division of Pediatric Neurology, Cohen Children's Medical Center, New Hyde Park, New York
2 shared publications- Sanjeev V. Kothare
Division of Pediatric Neurology, Department of Pediatrics, Cohen Children’s Medical Center, New Hyde Park, New York
2 shared publications
Latest Publications
- 30 March 2026
- Published by Elsevier in Pediatric Neurology
- Vol. 179, 114
Response to Interpreting Real-World Evidence on Doxepin and Mirtazapine for Pediatric Insomnia: Methodological Considerations
- 30 March 2026
- Published by Elsevier in Pediatric Neurology
- Vol. 179, 114
Response to Interpreting Real-World Evidence on Doxepin and Mirtazapine for Pediatric Insomnia: Methodological Considerations
- 19 November 2025
- Published by Elsevier in Pediatric Neurology
- Vol. 175, 151-155
Tactile Hallucinations in Pediatric and Young Adults With Narcolepsy: A Case Series and Review of the Literature
- 19 November 2025
- Published by Elsevier in Pediatric Neurology
- Vol. 175, 151-155
Tactile Hallucinations in Pediatric and Young Adults With Narcolepsy: A Case Series and Review of the Literature
- 16 November 2025
- Published by Elsevier in Pediatric Neurology
- Vol. 175, 111-115
Doxepin and Mirtazapine Use in Children and Adolescents With Symptoms of Insomnia — A Single-Center Retrospective Review
- 16 November 2025
- Published by Elsevier in Pediatric Neurology
- Vol. 175, 111-115
Doxepin and Mirtazapine Use in Children and Adolescents With Symptoms of Insomnia — A Single-Center Retrospective Review
- 5 September 2025
- Published by Wiley in Epileptic Disorders
- Vol. 27 (6) , 1201-1208
EEG ‐related deep tissue injuries in critically ill pediatric patients: A single institution quality improvement project
Introduction: Neurologic complications, including seizures, are common in pediatric patients undergoing heart surgery, especially those requiring postoperative extracorporeal membrane oxygenation (ECMO), requiring prompt, vigilant postoperative monitoring. Prolonged EEG monitoring in critically ill children presents a risk of scalp/pressure injuries. The skin's sensitivity to microcirculatory changes can also provide valuable insights into the patient's overall tissue perfusion, making it a critical component in the management of these vulnerable patients. Methods: We initiated a quality improvement (QI) project to assess and reduce scalp injuries related to prolonged EEG monitoring in critically ill neonates and infants. The project involved reviewing baseline data, which included 2336 inpatient video EEGs performed from January 2022 to December 2024, and implementing interventions to improve skin safety during electrode placement, while incorporating best practices from ACNS and ASET guidelines. Results: Five critically ill infants developed deep tissue injuries (DTIs) related to EEG electrodes, with most injuries occurring over the occipital region. The frequency of scalp injuries decreased from 0.30% in 2022 to 0% in 2024 after implementing the QI protocol, and was observed in conditions with known hypoperfusion. Discussion: Electrode‐related skin injuries are a common complication of prolonged EEG monitoring, particularly in critically ill pediatric patients. Our findings suggest that adherence to expert guidelines and tailored skin care protocols focused on skin preparation, electrode application, and monitoring parameters can reduce the risk of electrode‐related skin injuries. Further research is needed to refine safety protocols and address the unique skin care challenges faced by this high‐risk population.
- 5 September 2025
- Published by Wiley in Epileptic Disorders
- Vol. 27 (6) , 1201-1208
EEG ‐related deep tissue injuries in critically ill pediatric patients: A single institution quality improvement project
Introduction: Neurologic complications, including seizures, are common in pediatric patients undergoing heart surgery, especially those requiring postoperative extracorporeal membrane oxygenation (ECMO), requiring prompt, vigilant postoperative monitoring. Prolonged EEG monitoring in critically ill children presents a risk of scalp/pressure injuries. The skin's sensitivity to microcirculatory changes can also provide valuable insights into the patient's overall tissue perfusion, making it a critical component in the management of these vulnerable patients. Methods: We initiated a quality improvement (QI) project to assess and reduce scalp injuries related to prolonged EEG monitoring in critically ill neonates and infants. The project involved reviewing baseline data, which included 2336 inpatient video EEGs performed from January 2022 to December 2024, and implementing interventions to improve skin safety during electrode placement, while incorporating best practices from ACNS and ASET guidelines. Results: Five critically ill infants developed deep tissue injuries (DTIs) related to EEG electrodes, with most injuries occurring over the occipital region. The frequency of scalp injuries decreased from 0.30% in 2022 to 0% in 2024 after implementing the QI protocol, and was observed in conditions with known hypoperfusion. Discussion: Electrode‐related skin injuries are a common complication of prolonged EEG monitoring, particularly in critically ill pediatric patients. Our findings suggest that adherence to expert guidelines and tailored skin care protocols focused on skin preparation, electrode application, and monitoring parameters can reduce the risk of electrode‐related skin injuries. Further research is needed to refine safety protocols and address the unique skin care challenges faced by this high‐risk population.
- Open Access
- 10 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (10) , 3329
Sudden Unexpected Death in Epilepsy: A Narrative Review of Mechanism, Risks, and Prevention
Sudden unexpected death in epilepsy (SUDEP) is sudden, unexpected, witnessed or unwitnessed, nontraumatic, non-drowning death that occurs in a person with epilepsy. SUDEP is the leading cause of epilepsy-related death in adults with epilepsy, with an incidence of about 1.2 per 1000 person-years in the general epilepsy population. Recent studies have shown similar prevalence in the pediatric population too. Although the precise mechanism remains unclear, well-documented cases of SUDEP suggest that a generalized tonic clonic seizure-induced, centrally mediated change in cardiorespiratory function leads to terminal apnea and cardiac arrest. Risk factors include generalized tonic clonic seizure frequency, duration of epilepsy, nocturnal seizure, and certain genetic syndromes. Orexin, adenosine, and serotonin neurotransmission have been explored as novel drug targets to mitigate SUDEP risk. Neurostimulation and resective epilepsy surgery have been reported to have beneficial effects on long-term SUDEP risk as well. Future studies may aim to clarify the role of sleep and other comorbidities in SUDEP pathophysiology.
- 10 May 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (10) , 3329
Open AccessSudden Unexpected Death in Epilepsy: A Narrative Review of Mechanism, Risks, and Prevention
Sudden unexpected death in epilepsy (SUDEP) is sudden, unexpected, witnessed or unwitnessed, nontraumatic, non-drowning death that occurs in a person with epilepsy. SUDEP is the leading cause of epilepsy-related death in adults with epilepsy, with an incidence of about 1.2 per 1000 person-years in the general epilepsy population. Recent studies have shown similar prevalence in the pediatric population too. Although the precise mechanism remains unclear, well-documented cases of SUDEP suggest that a generalized tonic clonic seizure-induced, centrally mediated change in cardiorespiratory function leads to terminal apnea and cardiac arrest. Risk factors include generalized tonic clonic seizure frequency, duration of epilepsy, nocturnal seizure, and certain genetic syndromes. Orexin, adenosine, and serotonin neurotransmission have been explored as novel drug targets to mitigate SUDEP risk. Neurostimulation and resective epilepsy surgery have been reported to have beneficial effects on long-term SUDEP risk as well. Future studies may aim to clarify the role of sleep and other comorbidities in SUDEP pathophysiology.
- 26 April 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 169, 110426
Adjunctive use of cannabidiol in pediatric drug-resistant epilepsy: A retrospective multicenter analysis
- 26 April 2025
- Published by Elsevier in Epilepsy & Behavior
- Vol. 169, 110426
Adjunctive use of cannabidiol in pediatric drug-resistant epilepsy: A retrospective multicenter analysis